Apexigen lands $20M round as China biotech partners advance antibodies FierceBiotech A startup drug developer with close ties to China's biotech industry has landed a $20 million A round to push ahead with its clinical development work on antibodies that can help fight off cancer and inflammatory diseases. Apexigen, a Burlingame, CA ... Apexigen Secures $20 Million Series A1 Financing |
